Chromogranin A is a T cell antigen in human type 1 diabetes

Journal of Autoimmunity

Volumn 50, Issue , 2014, Pages 38-41

  Gottlieb, Peter A ^a   Delong, Thomas ^b   Baker, Rocky L ^b   Fitzgerald Miller, Lisa ^a   Wagner, Rebecca ^a   Cook, Gabrielle ^a   Rewers, Marian R ^a   Michels, Aaron ^a   Haskins, Kathryn ^b  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Autoantigen; Autoreactive CD4 T cells; Chromogranin A; Human; Post translational modification; Type 1 diabetes

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CHGA PROTEIN, HUMAN; CHROMOGRANIN A; HLA DQ ANTIGEN; HLA DQ8 ANTIGEN; PEPTIDE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ADOLESCENT; ADULT; CD4+ T LYMPHOCYTE; CHILD; DRUG EFFECTS; FEMALE; GENE EXPRESSION; GENETICS; HISTOCOMPATIBILITY TEST; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM; PATHOLOGY; PRIMARY CELL CULTURE;

ADOLESCENT; ADULT; ANTIGENS, CD4; AUTOANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHROMOGRANIN A; DIABETES MELLITUS, TYPE 1; FEMALE; GENE EXPRESSION; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HUMANS; MALE; PEPTIDES; PRIMARY CELL CULTURE; TRANSGLUTAMINASES;

EID: 84898808958     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2013.10.003     Document Type: Article

References (15)

1. Eisenbarth G.S. Type I diabetes mellitus. A chronic autoimmune disease. NEngl J Med 1986, 314:1360-1368.
2. Steinman L. Immune therapy for autoimmune diseases. Science 2004, 305:212-216.
3. Stadinski B.D., Delong T., Reisdorph N., Reisdorph R., Powell R.L., Armstrong M., et al. Chromogranin A is an autoantigen in type 1 diabetes. Nat Immunol 2010, 11:225-231.
4. Delong T., Baker R.L., He J., Barbour G., Bradley B., Haskins K. Diabetogenic T-cell clones recognize an altered peptide of chromogranin A. Diabetes 2012, 61:3239-3246.
5. Curry W.J., Shaw C., Johnston C.F., Thim L., Buchanan K.D. Isolation and primary structure of a novel chromogranin A-derived peptide, WE-14, from a human midgut carcinoid tumour. FEBS Lett 1992, 301:319-321.
6. Arif S., Tree T.I., Astill T.P., Tremble J.M., Bishop A.J., Dayan C.M., et al. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. JClin Invest 2004, 113:451-463.
7. Gianani R., Rabin D.U., Verge C.F., Yu L., Babu S.R., Pietropaolo M., et al. ICA512 autoantibody radioassay. Diabetes 1995, 44:1340-1344.
8. Yu L., Robles D.T., Abiru N., Kaur P., Rewers M., Kelemen K., et al. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci U S A 2000, 97:1701-1706.
9. Wenzlau J.M., Juhl K., Yu L., Moua O., Sarkar S.A., Gottlieb P., et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 2007, 104:17040-17045.
10. Wenzlau J.M., Frisch L.M., Hutton J.C., Davidson H.W. Mapping of conformational autoantibody epitopes in ZNT8. Diabetes/Metab Res Rev 2011, 27:883-886.
11. Alleva D.G., Crowe P.D., Jin L., Kwok W.W., Ling N., Gottschalk M., et al. Adisease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. JClin Invest 2001, 107:173-180.
12. Nagata M., Kotani R., Moriyama H., Yokono K., Roep B.O., Peakman M. Detection of autoreactive T cells in type 1 diabetes using coded autoantigens and an immunoglobulin-free cytokine ELISPOT assay: report from the fourth immunology of diabetes society T cell workshop. Ann N Y Acad Sci 2004, 1037:10-15.
13. Delong T., Baker R.L., He J., Haskins K. Novel autoantigens for diabetogenic CD4 T cells in autoimmune diabetes. Immunol Res 2013, 55:167-172.
14. Folk J.E., Finlayson J.S. The epsilon-(gamma-glutamyl)lysine crosslink and the catalytic role of transglutaminases. Adv Protein Chem 1977, 31:1-133.
15. Folk J.E. Transglutaminases. Annu Rev Biochem 1980, 49:517-531.